10x Genomics (TXG) vs Waystar Holding Corp. (WAY)
10x Genomics and Waystar Holding Corp. are both Health Information Services companies. 10x Genomics is the larger, with a market value of $11.1B against $4.7B — 2.3× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Waystar Holding Corp. trades at 34.3×. Waystar Holding Corp. grew revenue faster over the last twelve months: 19.2% against −4.28%. Waystar Holding Corp. has the higher net margin (11.2% vs −12.2%) and the higher return on invested capital (3.30% vs −20.2%). Across the 18 metrics below, Waystar Holding Corp. leads on 15 and 10x Genomics on 3.
Valuation
Profitability
| Metric | TXG | WAY | Health Information Services median |
|---|---|---|---|
| Gross margin | 70.03% | 69.11% | 63.38% |
| Operating margin | (14.33%) | 22.87% | (8.35%) |
| Net margin | (12.18%) | 11.18% | (14.70%) |
| Free cash flow margin | 19.68% | 20.42% | 0.58% |
| Return on equity | (9.40%) | 3.77% | (6.82%) |
| Return on assets | (7.47%) | 2.56% | (6.02%) |
| Return on invested capital | (20.20%) | 3.30% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack